benzyl N-[3-[(5S)-2-[(3,5-diamino-6-chloropyrazine-2-carbonyl)amino]-4,5-dihydro-1H-imidazol-5-yl]propyl]carbamate;3,5-diamino-N-[(5S)-5-(3-aminopropyl)-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-N-[(5S)-5-[3-(benzylcarbamoylamino)propyl]-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-N-[(5S)-5-[3-(benzylsulfonylamino)propyl]-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[(5S)-5-[3-[(2-phenylacetyl)amino]propyl]-4,5-dihydro-1H-imidazol-2-yl]pyrazine-2-carboxamide

C86H110Cl5N41O11S — CID 159006802

IUPACbenzyl N-[3-[(5S)-2-[(3,5-diamino-6-chloropyrazine-2-carbonyl)amino]-4,5-dihydro-1H-imidazol-5-yl]propyl]carbamate;3,5-diamino-N-[(5S)-5-(3-aminopropyl)-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-N-[(5S)-5-[3-(benzylcarbamoylamino)propyl]-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-N-[(5S)-5-[3-(benzylsulfonylamino)propyl]-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[(5S)-5-[3-[(2-phenylacetyl)amino]propyl]-4,5-dihydro-1H-imidazol-2-yl]pyrazine-2-carboxamide
SMILESNCCC[C@H]1CN=C(NC(=O)c2nc(Cl)c(N)nc2N)N1.Nc1nc(N)c(C(=O)NC2=NC[C@H](CCCNC(=O)Cc3ccccc3)N2)nc1Cl.Nc1nc(N)c(C(=O)NC2=NC[C@H](CCCNC(=O)NCc3ccccc3)N2)nc1Cl.Nc1nc(N)c(C(=O)NC2=NC[C@H](CCCNC(=O)OCc3ccccc3)N2)nc1Cl.Nc1nc(N)c(C(=O)NC2=NC[C@H](CCCNS(=O)(=O)Cc3ccccc3)N2)nc1Cl
InChIInChI=1S/C19H24ClN9O2.C19H23ClN8O3.C19H23ClN8O2.C18H23ClN8O3S.C11H17ClN8O/c20-14-16(22)28-15(21)13(27-14)17(30)29-18-24-10-12(26-18)7-4-8-23-19(31)25-9-11-5-2-1-3-6-11;20-14-16(22)27-15(21)13(26-14)17(29)28-18-24-9-12(25-18)7-4-8-23-19(30)31-10-11-5-2-1-3-6-11;20-15-17(22)27-16(21)14(26-15)18(30)28-19-24-10-12(25-19)7-4-8-23-13(29)9-11-5-2-1-3-6-11;19-14-16(21)26-15(20)13(25-14)17(28)27-18-22-9-12(24-18)7-4-8-23-31(29,30)10-11-5-2-1-3-6-11;12-7-9(15)19-8(14)6(18-7)10(21)20-11-16-4-5(17-11)2-1-3-13/h1-3,5-6,12H,4,7-10H2,(H4,21,22,28)(H2,23,25,31)(H2,24,26,29,30);1-3,5-6,12H,4,7-10H2,(H,23,30)(H4,21,22,27)(H2,24,25,28,29);1-3,5-6,12H,4,7-10H2,(H,23,29)(H4,21,22,27)(H2,24,25,28,30);1-3,5-6,12,23H,4,7-10H2,(H4,20,21,26)(H2,22,24,27,28);5H,1-4,13H2,(H4,14,15,19)(H2,16,17,20,21)/t4*12-;5-/m00000/s1
InChIKeyJSAFBIVIKFRQNP-JFUWCOFASA-N
MW2103.43 g/mol
LogP1.52
Rot. Bonds33

About benzyl N-[3-[(5S)-2-[(3,5-diamino-6-chloropyrazine-2-carbonyl)amino]-4,5-dihydro-1H-imidazol-5-yl]propyl]carbamate;3,5-diamino-N-[(5S)-5-(3-aminopropyl)-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-N-[(5S)-5-[3-(benzylcarbamoylamino)propyl]-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-N-[(5S)-5-[3-(benzylsulfonylamino)propyl]-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[(5S)-5-[3-[(2-phenylacetyl)amino]propyl]-4,5-dihydro-1H-imidazol-2-yl]pyrazine-2-carboxamide

benzyl N-[3-[(5S)-2-[(3,5-diamino-6-chloropyrazine-2-carbonyl)amino]-4,5-dihydro-1H-imidazol-5-yl]propyl]carbamate;3,5-diamino-N-[(5S)-5-(3-aminopropyl)-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-N-[(5S)-5-[3-(benzylcarbamoylamino)propyl]-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-N-[(5S)-5-[3-(benzylsulfonylamino)propyl]-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[(5S)-5-[3-[(2-phenylacetyl)amino]propyl]-4,5-dihydro-1H-imidazol-2-yl]pyrazine-2-carboxamide (PubChem CID 159006802) has the molecular formula C86H110Cl5N41O11S and a molecular weight of 2103.43 g/mol. Its IUPAC name is benzyl N-[3-[(5S)-2-[(3,5-diamino-6-chloropyrazine-2-carbonyl)amino]-4,5-dihydro-1H-imidazol-5-yl]propyl]carbamate;3,5-diamino-N-[(5S)-5-(3-aminopropyl)-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-N-[(5S)-5-[3-(benzylcarbamoylamino)propyl]-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-N-[(5S)-5-[3-(benzylsulfonylamino)propyl]-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[(5S)-5-[3-[(2-phenylacetyl)amino]propyl]-4,5-dihydro-1H-imidazol-2-yl]pyrazine-2-carboxamide.

Molecular Properties

Compound Namebenzyl N-[3-[(5S)-2-[(3,5-diamino-6-chloropyrazine-2-carbonyl)amino]-4,5-dihydro-1H-imidazol-5-yl]propyl]carbamate;3,5-diamino-N-[(5S)-5-(3-aminopropyl)-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-N-[(5S)-5-[3-(benzylcarbamoylamino)propyl]-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-N-[(5S)-5-[3-(benzylsulfonylamino)propyl]-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[(5S)-5-[3-[(2-phenylacetyl)amino]propyl]-4,5-dihydro-1H-imidazol-2-yl]pyrazine-2-carboxamide
PubChem CID159006802
Molecular FormulaC86H110Cl5N41O11S
Molecular Weight2103.43 g/mol
Exact Mass2099.75
IUPAC Namebenzyl N-[3-[(5S)-2-[(3,5-diamino-6-chloropyrazine-2-carbonyl)amino]-4,5-dihydro-1H-imidazol-5-yl]propyl]carbamate;3,5-diamino-N-[(5S)-5-(3-aminopropyl)-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-N-[(5S)-5-[3-(benzylcarbamoylamino)propyl]-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-N-[(5S)-5-[3-(benzylsulfonylamino)propyl]-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[(5S)-5-[3-[(2-phenylacetyl)amino]propyl]-4,5-dihydro-1H-imidazol-2-yl]pyrazine-2-carboxamide
SMILESNCCC[C@H]1CN=C(NC(=O)c2nc(Cl)c(N)nc2N)N1.Nc1nc(N)c(C(=O)NC2=NC[C@H](CCCNC(=O)Cc3ccccc3)N2)nc1Cl.Nc1nc(N)c(C(=O)NC2=NC[C@H](CCCNC(=O)NCc3ccccc3)N2)nc1Cl.Nc1nc(N)c(C(=O)NC2=NC[C@H](CCCNC(=O)OCc3ccccc3)N2)nc1Cl.Nc1nc(N)c(C(=O)NC2=NC[C@H](CCCNS(=O)(=O)Cc3ccccc3)N2)nc1Cl
InChIInChI=1S/C19H24ClN9O2.C19H23ClN8O3.C19H23ClN8O2.C18H23ClN8O3S.C11H17ClN8O/c20-14-16(22)28-15(21)13(27-14)17(30)29-18-24-10-12(26-18)7-4-8-23-19(31)25-9-11-5-2-1-3-6-11;20-14-16(22)27-15(21)13(26-14)17(29)28-18-24-9-12(25-18)7-4-8-23-19(30)31-10-11-5-2-1-3-6-11;20-15-17(22)27-16(21)14(26-15)18(30)28-19-24-10-12(25-19)7-4-8-23-13(29)9-11-5-2-1-3-6-11;19-14-16(21)26-15(20)13(25-14)17(28)27-18-22-9-12(24-18)7-4-8-23-31(29,30)10-11-5-2-1-3-6-11;12-7-9(15)19-8(14)6(18-7)10(21)20-11-16-4-5(17-11)2-1-3-13/h1-3,5-6,12H,4,7-10H2,(H4,21,22,28)(H2,23,25,31)(H2,24,26,29,30);1-3,5-6,12H,4,7-10H2,(H,23,30)(H4,21,22,27)(H2,24,25,28,29);1-3,5-6,12H,4,7-10H2,(H,23,29)(H4,21,22,27)(H2,24,25,28,30);1-3,5-6,12,23H,4,7-10H2,(H4,20,21,26)(H2,22,24,27,28);5H,1-4,13H2,(H4,14,15,19)(H2,16,17,20,21)/t4*12-;5-/m00000/s1
InChIKeyJSAFBIVIKFRQNP-JFUWCOFASA-N
XLogP1.52
TPSA837.30 Ų
H-Bond Donors26
H-Bond Acceptors42
Rotatable Bonds33
Heavy Atoms144
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002103.43
LogP ≤ 51.52
H-Bond Donors ≤ 526
H-Bond Acceptors ≤ 1042

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze benzyl N-[3-[(5S)-2-[(3,5-diamino-6-chloropyrazine-2-carbonyl)amino]-4,5-dihydro-1H-imidazol-5-yl]propyl]carbamate;3,5-diamino-N-[(5S)-5-(3-aminopropyl)-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-N-[(5S)-5-[3-(benzylcarbamoylamino)propyl]-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-N-[(5S)-5-[3-(benzylsulfonylamino)propyl]-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[(5S)-5-[3-[(2-phenylacetyl)amino]propyl]-4,5-dihydro-1H-imidazol-2-yl]pyrazine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of benzyl N-[3-[(5S)-2-[(3,5-diamino-6-chloropyrazine-2-carbonyl)amino]-4,5-dihydro-1H-imidazol-5-yl]propyl]carbamate;3,5-diamino-N-[(5S)-5-(3-aminopropyl)-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-N-[(5S)-5-[3-(benzylcarbamoylamino)propyl]-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-N-[(5S)-5-[3-(benzylsulfonylamino)propyl]-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[(5S)-5-[3-[(2-phenylacetyl)amino]propyl]-4,5-dihydro-1H-imidazol-2-yl]pyrazine-2-carboxamide?
The IUPAC name of benzyl N-[3-[(5S)-2-[(3,5-diamino-6-chloropyrazine-2-carbonyl)amino]-4,5-dihydro-1H-imidazol-5-yl]propyl]carbamate;3,5-diamino-N-[(5S)-5-(3-aminopropyl)-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-N-[(5S)-5-[3-(benzylcarbamoylamino)propyl]-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-N-[(5S)-5-[3-(benzylsulfonylamino)propyl]-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[(5S)-5-[3-[(2-phenylacetyl)amino]propyl]-4,5-dihydro-1H-imidazol-2-yl]pyrazine-2-carboxamide (CID 159006802) is benzyl N-[3-[(5S)-2-[(3,5-diamino-6-chloropyrazine-2-carbonyl)amino]-4,5-dihydro-1H-imidazol-5-yl]propyl]carbamate;3,5-diamino-N-[(5S)-5-(3-aminopropyl)-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-N-[(5S)-5-[3-(benzylcarbamoylamino)propyl]-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-N-[(5S)-5-[3-(benzylsulfonylamino)propyl]-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[(5S)-5-[3-[(2-phenylacetyl)amino]propyl]-4,5-dihydro-1H-imidazol-2-yl]pyrazine-2-carboxamide.
What is the SMILES notation for benzyl N-[3-[(5S)-2-[(3,5-diamino-6-chloropyrazine-2-carbonyl)amino]-4,5-dihydro-1H-imidazol-5-yl]propyl]carbamate;3,5-diamino-N-[(5S)-5-(3-aminopropyl)-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-N-[(5S)-5-[3-(benzylcarbamoylamino)propyl]-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-N-[(5S)-5-[3-(benzylsulfonylamino)propyl]-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[(5S)-5-[3-[(2-phenylacetyl)amino]propyl]-4,5-dihydro-1H-imidazol-2-yl]pyrazine-2-carboxamide?
The canonical SMILES for benzyl N-[3-[(5S)-2-[(3,5-diamino-6-chloropyrazine-2-carbonyl)amino]-4,5-dihydro-1H-imidazol-5-yl]propyl]carbamate;3,5-diamino-N-[(5S)-5-(3-aminopropyl)-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-N-[(5S)-5-[3-(benzylcarbamoylamino)propyl]-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-N-[(5S)-5-[3-(benzylsulfonylamino)propyl]-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[(5S)-5-[3-[(2-phenylacetyl)amino]propyl]-4,5-dihydro-1H-imidazol-2-yl]pyrazine-2-carboxamide is NCCC[C@H]1CN=C(NC(=O)c2nc(Cl)c(N)nc2N)N1.Nc1nc(N)c(C(=O)NC2=NC[C@H](CCCNC(=O)Cc3ccccc3)N2)nc1Cl.Nc1nc(N)c(C(=O)NC2=NC[C@H](CCCNC(=O)NCc3ccccc3)N2)nc1Cl.Nc1nc(N)c(C(=O)NC2=NC[C@H](CCCNC(=O)OCc3ccccc3)N2)nc1Cl.Nc1nc(N)c(C(=O)NC2=NC[C@H](CCCNS(=O)(=O)Cc3ccccc3)N2)nc1Cl.
What is the InChIKey of benzyl N-[3-[(5S)-2-[(3,5-diamino-6-chloropyrazine-2-carbonyl)amino]-4,5-dihydro-1H-imidazol-5-yl]propyl]carbamate;3,5-diamino-N-[(5S)-5-(3-aminopropyl)-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-N-[(5S)-5-[3-(benzylcarbamoylamino)propyl]-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-N-[(5S)-5-[3-(benzylsulfonylamino)propyl]-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[(5S)-5-[3-[(2-phenylacetyl)amino]propyl]-4,5-dihydro-1H-imidazol-2-yl]pyrazine-2-carboxamide?
The InChIKey is JSAFBIVIKFRQNP-JFUWCOFASA-N. The full InChI is InChI=1S/C19H24ClN9O2.C19H23ClN8O3.C19H23ClN8O2.C18H23ClN8O3S.C11H17ClN8O/c20-14-16(22)28-15(21)13(27-14)17(30)29-18-24-10-12(26-18)7-4-8-23-19(31)25-9-11-5-2-1-3-6-11;20-14-16(22)27-15(21)13(26-14)17(29)28-18-24-9-12(25-18)7-4-8-23-19(30)31-10-11-5-2-1-3-6-11;20-15-17(22)27-16(21)14(26-15)18(30)28-19-24-10-12(25-19)7-4-8-23-13(29)9-11-5-2-1-3-6-11;19-14-16(21)26-15(20)13(25-14)17(28)27-18-22-9-12(24-18)7-4-8-23-31(29,30)10-11-5-2-1-3-6-11;12-7-9(15)19-8(14)6(18-7)10(21)20-11-16-4-5(17-11)2-1-3-13/h1-3,5-6,12H,4,7-10H2,(H4,21,22,28)(H2,23,25,31)(H2,24,26,29,30);1-3,5-6,12H,4,7-10H2,(H,23,30)(H4,21,22,27)(H2,24,25,28,29);1-3,5-6,12H,4,7-10H2,(H,23,29)(H4,21,22,27)(H2,24,25,28,30);1-3,5-6,12,23H,4,7-10H2,(H4,20,21,26)(H2,22,24,27,28);5H,1-4,13H2,(H4,14,15,19)(H2,16,17,20,21)/t4*12-;5-/m00000/s1.
What are the key properties of benzyl N-[3-[(5S)-2-[(3,5-diamino-6-chloropyrazine-2-carbonyl)amino]-4,5-dihydro-1H-imidazol-5-yl]propyl]carbamate;3,5-diamino-N-[(5S)-5-(3-aminopropyl)-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-N-[(5S)-5-[3-(benzylcarbamoylamino)propyl]-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-N-[(5S)-5-[3-(benzylsulfonylamino)propyl]-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[(5S)-5-[3-[(2-phenylacetyl)amino]propyl]-4,5-dihydro-1H-imidazol-2-yl]pyrazine-2-carboxamide?
benzyl N-[3-[(5S)-2-[(3,5-diamino-6-chloropyrazine-2-carbonyl)amino]-4,5-dihydro-1H-imidazol-5-yl]propyl]carbamate;3,5-diamino-N-[(5S)-5-(3-aminopropyl)-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-N-[(5S)-5-[3-(benzylcarbamoylamino)propyl]-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-N-[(5S)-5-[3-(benzylsulfonylamino)propyl]-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[(5S)-5-[3-[(2-phenylacetyl)amino]propyl]-4,5-dihydro-1H-imidazol-2-yl]pyrazine-2-carboxamide has a molecular weight of 2103.43 g/mol, XLogP of 1.52, 33 rotatable bonds, 26 hydrogen bond donors, and 42 hydrogen bond acceptors.
Where does this data come from?
All data for benzyl N-[3-[(5S)-2-[(3,5-diamino-6-chloropyrazine-2-carbonyl)amino]-4,5-dihydro-1H-imidazol-5-yl]propyl]carbamate;3,5-diamino-N-[(5S)-5-(3-aminopropyl)-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-N-[(5S)-5-[3-(benzylcarbamoylamino)propyl]-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-N-[(5S)-5-[3-(benzylsulfonylamino)propyl]-4,5-dihydro-1H-imidazol-2-yl]-6-chloropyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[(5S)-5-[3-[(2-phenylacetyl)amino]propyl]-4,5-dihydro-1H-imidazol-2-yl]pyrazine-2-carboxamide is sourced from PubChem (CID 159006802), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).